BullFrog AI Holdings (BFRG) Accumulated Expenses (2021 - 2026)
BullFrog AI Holdings' (BFRG) quarterly Accumulated Expenses came in at $446507.0 in Q2 2026, up 22.69% on a YoY basis from $363922.0 in Q2 2025, and down 11.38% quarter-over-quarter from $503871.0 in Q4 2025.
Analysis
BullFrog AI Holdings (BFRG) Accumulated Expenses (2021 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Accumulated Expenses for 6 consecutive years, with $446507.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Accumulated Expenses rose 22.69% year-over-year to $446507.0; the trailing twelve-month figure through Jun 2026 stood at $446507.0 (up 22.69% YoY), and the FY2025 full-year result was $503871.0, up 231.15% from the prior year.
- Accumulated Expenses slipped to $446507.0 in Q2 2026 per BFRG's latest filing, from $503871.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $982988.0 in Q4 2022 and bottomed at $80694.0 in Q4 2023.
- Historically, Accumulated Expenses has averaged $366128.4 across 5 years, with a median of $337407.5 in 2023.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses surged 1333.83% in 2022, then slumped 91.79% in 2023.
- Over 5 years, Accumulated Expenses stood at $982988.0 in 2022, then plunged by 91.79% to $80694.0 in 2023, then surged by 88.56% to $152156.0 in 2024, then soared by 231.15% to $503871.0 in 2025, then retreated by 11.38% to $446507.0 in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $446507.0, $503871.0, and $534883.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 446,507.00 |
| Dec 31, 2025 | 503,871.00 |
| Sep 30, 2025 | 534,883.00 |
| Jun 30, 2025 | 363,922.00 |
| Mar 31, 2025 | 464,794.00 |
| Dec 31, 2024 | 152,156.00 |
| Sep 30, 2024 | 515,658.00 |
| Jun 30, 2024 | 268,437.00 |
| Mar 31, 2024 | 182,834.00 |
| Dec 31, 2023 | 80,694.00 |
| Sep 30, 2023 | 122,257.00 |
| Jun 30, 2023 | 195,903.00 |
| Mar 31, 2023 | 310,893.00 |
| Dec 31, 2022 | 982,988.00 |
| Dec 31, 2021 | 68,557.00 |